[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pancreatic-solid-lesions\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pancreatic-solid-lesions":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100651564","eus-dfi-in-solid-pancreatic-lesions-100651564",false,"NCT07763561","EUS-DFI in Solid Pancreatic Lesions","Role of Endoscopic Ultrasound-guided Detective Flow Imaging (EUS-DFI) for the Evaluation of Solid Pancreatic Tumours: A Prospective, International Multicenter Study","DFI","Inclusion Criteria:\n\n* Adults aged 18 years or older.\n* Presence of a solid pancreatic lesion identified during endoscopic ultrasound (EUS), regardless of the indication for the examination.\n* Ability and willingness to provide written informed consent.\n\nExclusion Criteria:\n\n* Predominantly cystic pancreatic lesions.\n* Anatomical abnormalities preventing adequate EUS examination.\n* Limited ability to understand the study procedures or provide informed consent.\n* Refusal to sign the informed consent form.","ALL","18 Years",{"count":20,"type":21},48,"ESTIMATED","OBSERVATIONAL","This prospective, international, multicenter observational study aims to evaluate the role of Endoscopic Ultrasound-guided Detective Flow Imaging (EUS-DFI) in the characterization of solid pancreatic lesions. The study will assess microvascularization patterns identified by EUS-DFI and their association with the final diagnosis, using histopathology or clinical follow-up as the reference standard. Secondary objectives include evaluating interobserver agreement and the diagnostic accuracy of DFI vascular patterns for differentiating benign and malignant pancreatic lesions.",[25,26],"Pancreatic Neoplasms","Pancreatic Solid Lesions","NOT_YET_RECRUITING","2026-08-12",{"date":30,"type":31},"2026-08-13","ACTUAL",{"date":33,"type":21},"2026-12-01",{"date":35,"type":21},"2027-12-31",{"name":37,"class":38},"Julio Iglesias García","OTHER",{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":46,"enrollmentInfo":47,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":49,"conditions":50,"keywords":51,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":64},"100440696","artificial-intelligence-ai-cytopathology-trial-100440696","NCT05018663","Artificial Intelligence (AI) Cytopathology Trial","Artificial Intelligence for Rapid On-site Evaluation (AI-ROSE) for Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA) Biopsy of Pancreatic Solid Lesions: A Prospective Double Blinded Study","Inclusion Criteria:\n\n* Have EUS finding of a PSL;\n* Do not have contraindications for FNA\u002FFNB.\n\nExclusion Criteria:\n\n* Inability to provide informed consent for the procedure;\n* Contraindication for FNA\u002FFNB eg coagulopathy, lack of avascular window for FNA.","100 Years",{"count":48,"type":21},50,"Purpose The primary objective of the study is to compare interpretation of EUS FNA\u002FFNB samples for adequacy between ROSE and AI at bedside. To compare accuracy of preliminary diagnosis results between ROSE and AI at bedside versus final pathology report.\n\nResearch design This is a prospective single center study to compare performance characteristics in the interpretation of EUS FNA\u002FFNB samples between AI and ROSE.\n\nProcedures to be used Eligible patients will undergo EUS guided FNA\u002FFNA of PSLs using standard of care. Sample slides are prepared by a cytopathologist at bedside and observed under a microscope. At the same time, the slides are scanned using a slide scanner and those images are saved for interpretation by AI at a later time.",[26],[52,53],"Endoscopic Ultrasound guided fine needle aspiration (FNA)","Endoscopic Ultrasound guided fine needle biopsy (FNB)","RECRUITING","2023-02-15",{"date":57,"type":31},"2023-02-16",{"date":59,"type":31},"2021-07-21",{"date":61,"type":21},"2028-01-30",{"name":63,"class":38},"The University of Texas Health Science Center, Houston",1]